# Sorafenib and High-Dose Carboplatin, Paclitaxel, and External-Beam Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer

> **NCT00547443** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **University of Texas Southwestern Medical Center**

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** carboplatin
- **DRUG:** paclitaxel
- **DRUG:** sorafenib tosylate
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00547443
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2007-07
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Withdrawn as the sponsor has stopped the drug for NSCLC population
- **Last updated:** 2019-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00547443

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00547443, "Sorafenib and High-Dose Carboplatin, Paclitaxel, and External-Beam Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00547443. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*